Submitted by Anonymous (not verified) on 18 July 2025 - 13:19
Human medicines European public assessment report (EPAR): Soliris, eculizumab, Date of authorisation: 20/06/2007, Revision: 40, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Soliris, eculizumab, Date of authorisation: 20/06/2007, Revision: 40, Status: Authorised